Pegylated Interferon Alfa clinical trials
How each study uses Pegylated Interferon Alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Pegylated Interferon Alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2016 (4)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2005 | 1 |
| 2011 | 1 |
| 2016 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 11
Third Affiliated Hospital, Sun Yat-Sen University (7) · Memorial Sloan Kettering Cancer Center (2) · Brii Biosciences Limited (1) · National Cancer Institute (NCI) (1) · Xiamen Amoytop Biotech Co., Ltd. (1) · Merck Sharp & Dohme LLC (1) · Assembly Biosciences (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)
Often tested with
Tested in the same studies.
Peginterferon alfa-2a (1) · Valopicitabine (1) · Tenofovir (1) · Vebicorvir (1)
Studies
Open first, then newest update. How each study uses Pegylated Interferon Alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.RecruitingPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT04640129Written as PEG-Interferon Alfa, Tenofovir Disoproxil FumarateHow we know
- Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV PatientsCompletedPhase 2Brii Biosciences LimitedNCT05970289Written as PEG-IFNαHow we know
- The Clinical Cure Project of Chronic Hepatitis B in ChinaActive, not recruitingPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT04035837Written as pegylated interferon-alfaHow we know
- A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus InfectionTerminatedPhase 2Assembly BiosciencesNCT04781647Written as Peg-IFNαHow we know
- The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT02745704Written as Peginterferon alfaHow we know
- The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT02838810Written as peginterferon alfaHow we know
- The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAgStatus unknownPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT03801538Written as Peginterferon AlfaHow we know
- HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection PatientsStatus unknownPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT02908763Written as peginterferon alfaHow we know
- The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAgStatus unknownPhase 4Third Affiliated Hospital, Sun Yat-Sen UniversityNCT02893124Written as peginterferon alfaHow we know
- Interferon Alfa Following Surgery in Treating Patients With Stage III MelanomaStatus unknownPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT00006249Written as pegylated interferon alfaHow we know
- Interferon Alfa in Treating Patients With Advanced Kidney CancerCompletedPhase 1/2Memorial Sloan Kettering Cancer CenterNCT00003542Written as pegylated interferon alfaHow we know
- Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's LymphomaCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00006039Written as pegylated interferon alfaHow we know
- A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine GliomasCompletedPhase 2National Cancer Institute (NCI)NCT00036569Written as pegylated interferon alfaHow we know
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Assessment of Ypeginterferon Alfa-2a in Healthy SubjectsCompletedPhase 1Xiamen Amoytop Biotech Co., Ltd.NCT01343186Written as Peginterferon alfaHow we know
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis CCompletedPhase 2Merck Sharp & Dohme LLCNCT00118768Written as Pegylated Interferon AlfaHow we know
Given beside what is tested · 9 — Pegylated Interferon Alfa is usual care or a partner of the new treatment
- A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)RecruitingPhase 2Brii Biosciences LimitedNCT06650852Written as PEG-IFNαHow we know
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (B)RecruitingPhase 2The Second Affiliated Hospital of Chongqing Medical UniversityNCT07845058Written as PEG-IFNαHow we know
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)RecruitingPhase 2The Second Affiliated Hospital of Chongqing Medical UniversityNCT05771402Written as Peg-IFNαHow we know
- ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus InfectionRecruitingPhase 4The Second Affiliated Hospital of Chongqing Medical UniversityNCT07573943Written as Peg-IFNαHow we know
- Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)CompletedPhase 2Brii Biosciences LimitedNCT06491563Written as PEG-IFNαHow we know
- Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus InfectionCompletedPhase 2Vir Biotechnology, Inc.NCT04856085Written as PEG-IFNαHow we know
- A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B InfectionCompletedPhase 1/2Vir Biotechnology, Inc.NCT05612581Written as PEG-IFNαHow we know
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnPhase 2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT03575208Written as Pegylated interferon alfa (pegIFN)How we know
- Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis DStatus unknownPhase 2Aga Khan UniversityNCT03105310Written as Pegylated interferon alfaHow we know